Your browser doesn't support javascript.
loading
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
Néant, Nadège; Gattacceca, Florence; Lê, Minh Patrick; Yazdanpanah, Yazdan; Dhiver, Catherine; Bregigeon, Sylvie; Mokhtari, Saadia; Peytavin, Gilles; Tamalet, Catherine; Descamps, Diane; Lacarelle, Bruno; Solas, Caroline.
Afiliación
  • Néant N; INSERM U911-CRO2 SMARTc, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France. nadege.neant@ap-hm.fr.
  • Gattacceca F; INSERM U911-CRO2 SMARTc, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France.
  • Lê MP; APHP, Hôpital Bichat-Claude Bernard, Laboratoire de Pharmaco-Toxicologie, IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and INSERM, 75018, Paris, France.
  • Yazdanpanah Y; APHP, IAME-UMR 1137, Hôpital Bichat-Claude Bernard, Service des Maladies Infectieuses et Tropicales, Univ Paris Diderot, 75018, Paris, France.
  • Dhiver C; IHU Méditerranée Infection, Aix Marseille Univ., AP-HM, URMITE UM 63 CNRS 7278 IRD 198 INSERM 1095, 13005, Marseille, France.
  • Bregigeon S; APHM, Hôpital Sainte-Marguerite, Service d'Immuno-hématologie clinique, 13009, Marseille, France.
  • Mokhtari S; IHU Méditerranée Infection, Aix Marseille Univ., AP-HM, URMITE UM 63 CNRS 7278 IRD 198 INSERM 1095, 13005, Marseille, France.
  • Peytavin G; APHP, Hôpital Bichat-Claude Bernard, Laboratoire de Pharmaco-Toxicologie, IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and INSERM, 75018, Paris, France.
  • Tamalet C; IHU Méditerranée Infection, Aix Marseille Univ., AP-HM, URMITE UM 63 CNRS 7278 IRD 198 INSERM 1095, 13005, Marseille, France.
  • Descamps D; APHP, Hôpital Bichat-Claude Bernard, Laboratoire de Virologie, IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and INSERM, 75018, Paris, France.
  • Lacarelle B; INSERM U911-CRO2 SMARTc, Aix-Marseille University, 27 Boulevard Jean Moulin, 13005, Marseille, France.
  • Solas C; Aix-Marseille Univ, APHM, INSERM U911-CRO2, SMARTc, Hôpital La Timone, Laboratoire de Pharmacocinétique et Toxicologie, 13005, Marseille, France.
Eur J Clin Pharmacol ; 74(4): 473-481, 2018 Apr.
Article en En | MEDLINE | ID: mdl-29374296
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH / Combinación Emtricitabina, Rilpivirina y Tenofovir / Modelos Biológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH / Combinación Emtricitabina, Rilpivirina y Tenofovir / Modelos Biológicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: Francia